|
|
|
|
|
Neuro-Oncology
Reviews
|
|
|
|
Volume
28 Number 13
10 May 2026
|
|
|
|
Home
>
Publications
>
Neuro-Oncology
Reviews >
Volume
28, Year 2026 >
Number 13, 10 May
|
|
|
|
|
|
Khaliq HMH.
Tumour Microenvironment in
Brain Cancer: A Neural Niche or a Hijacked Memory System?
J
Coll Physicians Surg Pak. 2026 May;36(5):569-570. doi:
10.29271/jcpsp.2026.05.569. PMID:
42152192. ˍ
|
|
|
|
Pinzón-Ramírez
V, Cueva-Cañola LE, Natera DE, Olivera HEA,
Camacho-Hernández OE, Beltran-De la Fuente AC,
Ramirez-Alvarez SA, Cubas EYG, Flores GV, Gamez ME, Castilla LR.
Clinical
outcomes of adding vincristine to procarbazine-lomustine in
patients with gliomas: insights from current
evidence.
Ecancermedicalscience.
2026 May 1;20:2115. doi:
10.3332/ecancer.2026.2115. PMID:
42416239. ˍ
|
|
|
|
Arjeini Y, Khalili Dermani S, Sadeh S, Abdolalipour E, Saberpour
M, Zargaran H, Mohebbi SR, Ghaemi A.
Oncolytic
viruses in brain cancer therapy: advances, challenges, and
clinical trial outcomes.
Immunotherapy.
2026 May 4;18(3):249-270. doi:
10.1080/1750743X.2026.2640755. PMID:
42077101˰ ˍ
|
|
|
|
Halac E, Begagic E, Pojskic M, Arnautovic K.
Treatment
Strategies and Outcomes for Spinal Low-grade Gliomas: A Systematic
Review of the Past Quarter Century.
Neurosurg
Clin N Am. 2026 May 6;37(3):331-351. doi:
10.1016/j.nec.2026.03.008. PMID:
42264663˰ ˍ
|
|
|
|
Abuliezi N, Sun Y, Zhao J, Qu X,
Wu Y, Liao T, Kuerban G, Dun X, Wu Q.
Efficacy
and safety of tumor treating fields (TTF) combined with
chemotherapy versus chemotherapy only in the treatment of
glioblastoma: a systematic review and meta-analysis.
Front
Med (Lausanne).
2026 May 8;13:1812119. doi:
10.3389/fmed.2026.1812119. PMID:
42180742. ˍ
|
|
|
|
Dvir
R, Elhasid R, Roth J, Constantini S, Peled Y, Ospovat I, Shiran
SI.
Pediatric
metastatic medulloblastoma: upfront biopsy followed by oncological
treatment without excision of the primary tumor.
J
Neurosurg Pediatr.
2026 May 8:1-8. doi: 10.3171/2025.12.PEDS25467. PMID: 42102399. ˍ
|
|
|
|
Leeper HE, Oliver K, Bulbeck H, Johnson MO.
Translating
Cancer Science Into Cancer Care: Using Serious Illness
Communication Frameworks to Deliver High-Quality Person-Centered
Care in Neuro-Oncology.
Am
Soc Clin Oncol Educ Book. 2026 May 8;46(3):e525426.
doi:
10.1200/EDBK-26-525426. PMID:
42102343. ˍ
|
|
|
|
Sung
JY, Hwang K.
Glioblastoma:
epidemiology, molecular pathogenesis, diagnosis, management, and
therapeutic resistance.
Mol
Biomed.
2026 May 8;7(1):63. doi:
10.1186/s43556-026-00467-8. PMID:
42101535. ˍ
|
|
|
|
Welch RL, Moziak K, Zang X,
Martin AM.
Immune
checkpoint inhibitors in medulloblastoma: current updates in
preclinical and clinical developments.
Front
Oncol. 2026
May 8;16:1725230. doi:
10.3389/fonc.2026.1725230. PMID:
42180054. ˍ
|
|
|
|
|
|
|
|
|
|
|
|
|